Our Leadership

Scott Luce
Chief Executive Officer

Scott brings more than three decades of pharmaceutical industry leadership experience to SCA Pharma.

Previously, Scott was an operating partner at The Vistria Group, where he helped to develop and execute its health-care sector investment strategy. He has also held executive leadership roles in general management, sales and marketing, and business development with both Abbott and Baxter.

Scott holds a bachelor’s degree in marketing from Indiana University, and an MBA from Lake Forest Graduate School of Management.

Louis Pace
Chief Financial Officer and Chief Information Officer

Louis Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and leadership roles. Most recently, Mr. Pace served as Chief Financial Officer at Orchid Orthopedic Solutions where he successfully led strategy deployment efforts that focused on growth and profitability improvement.

Mr. Pace holds an AB in Economics from Harvard University and an MBA from Northwestern Kellogg Graduate School of Management.

Racheal Adams, PharmD
Chief Pharmacy Officer

Racheal serves as a liaison with regulatory entities, strategic partners and customers. She also plays a critical role in product portfolio development.

An employee of SCA Pharma since its start, Racheal has served in multiple quality roles including director of corporate quality. With 20+ years of experience in sterile compounding, she holds certificates in primary compounding and high-risk sterile compounding.

Racheal earned her Doctor of Pharmacy degree from the University of Arkansas for Medical Sciences.

Ken Bonnell
Chief Quality Officer

Ken Bonnell joins SCA Pharma as the Chief Quality Officer (CQO), bringing over 30 years of expertise in Quality, Operations, and Regulatory Affairs compliance. His transformative leadership at Aldevron, a Danaher Company, earned the facility a “No Action Indicated” status from the FDA, contributing significantly to the COVID-19 vaccine production. Previously, Ken held pivotal roles at Teligent Pharma, Merck, and PCI Pharma, enhancing compliance and quality standards.

Ken’s academic credentials include an M.S. in Molecular Biology from the University of Nebraska at Kearney, an M.B.A. in Business Management from Montgomery University, and a B.S. in from Mary Washington University. Ken also holds a Six Sigma Black Belt certification from Villanova University, and he has also co-authored a chapter on Orphan Diseases in the Regulatory Affairs Handbook published by RAPS.